Nonketotic hyperglycinemia

1970 ◽  
Vol 77 (1) ◽  
pp. 164-165 ◽  
Author(s):  
A. Okken ◽  
C.J. de Groot ◽  
F.A. Hommes
2015 ◽  
Vol 03 (04) ◽  
pp. 207-215
Author(s):  
Julia Hennermann

2021 ◽  
Author(s):  
Oya Kuseyri Hübschmann ◽  
Natalia Alexandra Julia Palacios ◽  
Mireia Olivella ◽  
Philipp Guder ◽  
Dimitrios I. Zafeiriou ◽  
...  

PEDIATRICS ◽  
1995 ◽  
Vol 95 (1) ◽  
pp. 142-146
Author(s):  
Satoshi Matsuo ◽  
Fumio Inoue ◽  
Yoshihiro Takeuchi ◽  
Hiroshi Yoshioka ◽  
Akihiko Kinugasa ◽  
...  

Nonketotic hyperglycinemia (NKH) is a rare inherited disease caused by a defect of the glycine cleavage enzyme.1 Especially in the neonatal type, neurological symptoms such as muscular hypotonia, seizures, respiratory distress, and lethargy develop rapidly, and the prognosis is unfavorable.1 Elevation of glycine in the cerebrospinal fluid (CSF) is thought to be responsible for these symptoms. However, management is quite difficult, because it is not well understood how elevation of glycine causes these symptoms. Lowering of the glycine level in CSF with sodium benzoate is not enough to avoid severe psychomotor and mental retardation. The N-methyl-D-aspartate (NMDA) receptor, which is one of the excitatory amino acid receptors, has a glycine binding site.2


1978 ◽  
Vol 15 (2) ◽  
pp. 85-88
Author(s):  
Creig S Hoyt ◽  
Richard A Brown

2018 ◽  
Vol 33 (8) ◽  
pp. 549-550
Author(s):  
J. Contreras-Roura ◽  
I. Camayd-Viera ◽  
A.D. Padrón-Díaz ◽  
L. Martínez-Rey

2021 ◽  
Vol 18 (4) ◽  
Author(s):  
Teresa Almeida ◽  
Isabel Tavares Almeida ◽  
Andreia Forno ◽  
Luis Rodrigues ◽  
Rita Jotta ◽  
...  

2013 ◽  
Vol 32 (2) ◽  
pp. 95-103 ◽  
Author(s):  
Joanna L. Mulligan

Nonketotic hyperglycinemia (NKH) is an autosomal recessive inborn error of glycine metabolism. In this article, I will present the case of baby girl S. who presented to the emergency room on Day 4 of life with severe lethargy, seizures, and respiratory depression requiring mechanical ventilation. A diagnosis of NKH was made secondary to elevated plasma and cerebrospinal fluid glycine concentrations. I will review the pathophysiology of NKH, methods of diagnosis, and the differential diagnosis. There are a variety of different pharmacologic and alternative therapies for NKH. Despite these treatments, the prognosis for infants with NKH is poor, with severe neurologic impairment, intractable seizures, and death common before 5 years of age. I will address the role of the advanced practice nurse in caring for an infant with NKH including clinical, educational, and research implications.


PEDIATRICS ◽  
1981 ◽  
Vol 67 (1) ◽  
pp. 162-163
Author(s):  
Barry Wolf ◽  
Elsa P. Paulsen ◽  
F. E. Dreifuss

MacDermont et al1 (Pediatrics 65:624, 1980) have described the uncomplicated efficacy of valproate in treating the seizures of two patients with nonketotic hyperglycinemia even though valproate elevates urinary and serum glycine concentrations in individuals with convulsive disorders.2,3 Recent observations of increased urinary propionate excretion as a metabolic consequence of valproate therapy in two patients with seizures seem to contraindicate its use in children with disorders of propionate metabolism.4 However, we have successfully and safely used valproate to control seizures in a patient with propionyl coenzyme A carboxylase (PCC) deficiency, a disorder characterized by both hyperglycinemia and propionic acidemia.


Sign in / Sign up

Export Citation Format

Share Document